BioCentury
ARTICLE | Company News

DDDP and BMY revise drug discovery agreement

December 18, 2000 8:00 AM UTC

3-Dimensional Pharmaceuticals will return $4.5 million to Bristol-Myers out of the total $23.5 million upfront fee paid under the companies' drug discovery collaboration earlier this year ( see BioCen...